Metsä Board Oyj (METSA.HE)

Negative revenue growth while UPM.HE stands at 3.06%. Joel Greenblatt would look for strategic missteps or cyclical reasons.

Negative gross profit growth while UPM.HE is at 651.18%. Joel Greenblatt would examine cost competitiveness or demand decline.

Negative EBIT growth while UPM.HE is at 78.42%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.

Negative operating income growth while UPM.HE is at 78.42%. Joel Greenblatt would press for urgent turnaround measures.

Negative net income growth while UPM.HE stands at 81.90%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.

Negative EPS growth while UPM.HE is at 81.97%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.

Negative diluted EPS growth while UPM.HE is at 81.97%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.

Share reduction while UPM.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.

Reduced diluted shares while UPM.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.

No Data available this quarter, please select a different quarter.

Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.

Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.

Negative 10Y revenue/share CAGR while UPM.HE stands at 14.57%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.

Negative 5Y CAGR while UPM.HE stands at 4.77%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.

Negative 3Y CAGR while UPM.HE stands at 6.14%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.

Negative 10Y OCF/share CAGR while UPM.HE stands at 14.97%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.

Negative 5Y OCF/share CAGR while UPM.HE is at 59.54%. Joel Greenblatt would question the firm’s operational model or cost structure.

Negative 3Y OCF/share CAGR while UPM.HE stands at 7.99%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.

Net income/share CAGR at 50-75% of UPM.HE's 301.44%. Martin Whitman might question if the firm’s product or cost base lags behind.

Below 50% of UPM.HE's 1535.45%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.

Below 50% of UPM.HE's 207.36%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.

Below 50% of UPM.HE's 56.35%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.

3Y equity/share CAGR at 75-90% of UPM.HE's 23.34%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.

No Data available this quarter, please select a different quarter.

No Data available this quarter, please select a different quarter.

No Data available this quarter, please select a different quarter.

Inventory growth well above UPM.HE's 3.07%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.

Asset growth well under 50% of UPM.HE's 5.89%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.

50-75% of UPM.HE's 6.65%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.

SG&A growth of 1.04% while UPM.HE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.